Wensaas K A, Hanevik K, Hausken T, Eide G E, Langeland N, Mørch K, Rortveit G
Research Unit for General Practice, Uni Research Health, Bergen, Norway.
Department of Clinical Science, University of Bergen, Bergen, Norway.
Neurogastroenterol Motil. 2016 Oct;28(10):1561-9. doi: 10.1111/nmo.12856. Epub 2016 May 18.
Irritable bowel syndrome (IBS) is a common complication following gastroenteritis, and a high prevalence of postgiardiasis IBS has previously been reported. This study aims to investigate the prevalence, adjusted relative risk (RRadj), and overlap of different functional gastrointestinal disorders (FGID) according to Rome III criteria following infection with Giardia lamblia.
All patients ≥18 years of age with verified giardiasis during an outbreak in 2004, and a control group matched by age and gender, were mailed a questionnaire 3 years later.
The prevalence of functional dyspepsia (FD) was 25.9% in the exposed and 6.9% in the control group, RRadj: 3.9 (95% confidence intervals [CI]: 3.1-4.8). The prevalence of IBS was 47.9% and 14.3%, respectively, with RRadj: 3.4 (95% CI: 3.0-3.8). Prevalence of other gastrointestinal symptoms ranged from 70.0% vs 39.7% for bloating (RRadj: 1.8) to 8.3% vs 2.9% for nausea (RRadj: 3.0) in the Giardia and the control group, respectively. Among individuals fulfilling criteria for IBS 44% in the exposed group and 29% in the control group also fulfilled criteria for FD. IBS subtypes based on Rome III criteria (stool consistency) showed poor agreement with subtypes based on frequency of bowel movements (Kappa-values: 0.17 and 0.27).
CONCLUSIONS & INFERENCES: There were high prevalences and RRs of IBS, FD and other gastrointestinal symptoms following acute giardiasis, and a high degree of overlap between the disorders. The agreement between different IBS subtype criteria varied, and there were also differences between the exposed and control group.
肠易激综合征(IBS)是肠胃炎后的常见并发症,先前已有关于贾第虫病后IBS高患病率的报道。本研究旨在根据罗马III标准调查感染蓝氏贾第鞭毛虫后不同功能性胃肠疾病(FGID)的患病率、校正相对风险(RRadj)及重叠情况。
2004年一次疫情期间确诊为贾第虫病的所有≥18岁患者以及按年龄和性别匹配的对照组,在3年后收到一份问卷。
暴露组功能性消化不良(FD)的患病率为25.9%,对照组为6.9%,RRadj:3.9(95%置信区间[CI]:3.1 - 4.8)。IBS的患病率分别为47.9%和14.3%,RRadj:3.4(95% CI:3.0 - 3.8)。在贾第虫组和对照组中,其他胃肠道症状的患病率从腹胀的70.0%对39.7%(RRadj:1.8)到恶心的8.3%对2.9%(RRadj:3.0)不等。在符合IBS标准的个体中,暴露组44%、对照组29%也符合FD标准。基于罗马III标准(粪便稠度)的IBS亚型与基于排便频率的亚型一致性较差(卡帕值:0.17和0.27)。
急性贾第虫病后IBS、FD和其他胃肠道症状的患病率及RRadj均较高,且疾病之间存在高度重叠。不同IBS亚型标准之间的一致性各异,暴露组和对照组之间也存在差异。